Recap: Evaxion Biotech Q4 Earnings

Evaxion Biotech EVAX reported its Q4 earnings results on Wednesday, March 27, 2024 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Evaxion Biotech beat estimated earnings by 90.0%, reporting an EPS of $-0.16 versus an estimate of $-1.6.

Revenue was up $73 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.2 which was followed by a 7.000000000000001% increase in the share price the next day.

To track all earnings releases for Evaxion Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.